Browsing by Author Munoz (nee Gyurosiova), Lenka

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 5 of 5
Issue DateTitleAuthor(s)Citation
2013The 3,7-diazabicyclo[3.3.1]nonane scaffold for subtype selective nicotine acetylcholine receptor (nAChR) ligands. Part 1: the influence of different hydrogen bond acceptor systems on alkyl and (hetero)aryl substituentsMunoz (nee Gyurosiova), Lenka; Eibl, Christoph; Gundisch, Daniela; Papke, Roger; Stokes, Clare; Tomassoli, Isabelle; School of Medical Sciences: PharmacologyThe 3,7-diazabicyclo[3.3.1]nonane scaffold for subtype selective nicotine acetylcholine receptor (nAChR) ligands. Part 1: the influence of different hydrogen bond acceptor systems on alkyl and (hetero)aryl substituents, Bioorganic and Medicinal Chemistry, vol.21, 23, 2013,pp 7283-7308
2010Fluorescence polarization binding assay to develop inhibitors of inactive p38alpha mitogen-activated protein kinaseMunoz (nee Gyurosiova), Lenka; Yeung, Otto Yiu To; Hauser, Dominik; Laufer, Stefan; Peifer, Christian; Selig, Roland; Pharmacy; PharmacyFluorescence polarization binding assay to develop inhibitors of inactive p38alpha mitogen-activated protein kinase, Analytical Biochemistry, vol.401, 1,pp 125-133
2013Interleukins in glioblastoma pathophysiology: implications for therapyGrewal, (Ranjit) Thomas; Munoz (nee Gyurosiova), Lenka; Yeung, Otto Yiu To; McDonald, K; Pharmacy; School of Medical Sciences: Pharmacology; PharmacyInterleukins in glioblastoma pathophysiology: implications for therapy, British Journal of Pharmacology, vol.168, 3, 2013,pp 591-606
2007A novel p38α MAPK inhibitor suppresses brain proinflammatory cytokine up-regulation and attenuates synaptic dysfunction and behavioral deficits in an Alzheimer's disease mouse model.Munoz (nee Gyurosiova), Lenka; Chico, Laura Wing; Craft, Jeffrey M; Hu, Wenhui; McNamara, Laurie K; Ranaivo, Hantamalala Ralay; Roy, Saktimayee M; Van Eldik, Linda J; Watterson, D Martin; PharmacyA novel p38α MAPK inhibitor suppresses brain proinflammatory cytokine up-regulation and attenuates synaptic dysfunction and behavioral deficits in an Alzheimer's disease mouse model., Journal of Neuroinflammation, vol.4,(21),2007,pp Published online 2007 September 4. doi: 10.1186/17-N/A
2012p38 MAPK inhibitors attenuate pro-inflammatory cytokine production and the invasiveness of human U251 glioblastoma cellsBryce, Nicole; Grewal, (Ranjit) Thomas; Konayagi, Mari; Munoz (nee Gyurosiova), Lenka; Yeung, Otto Yiu To; Adams, Seray; Braidy, Nady; Guillemin, Gilles; McDonald, K; Teo, Charlie; Chemistry; Pharmacy; Pharmacy; Pharmacy; Pharmacyp38 MAPK inhibitors attenuate pro-inflammatory cytokine production and the invasiveness of human U251 glioblastoma cells, Journal of Neuro-Oncology, vol.109, 1, 2012,pp 35-44